Re: First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial. K. O. Kagan, R. Sroka, J. Sonek, H. Abele, K. Lüthgens, M. Schmid, P. Wagner, S. Brucker, D. Wallwiener and M. Hoopmann. Ultrasound Obstet Gynecol 2018; 51: 437-444
| Autor: | Lisa Hui |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Risk Assessment law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial law Pregnancy medicine Humans Radiology Nuclear Medicine and imaging 030212 general & internal medicine Ultrasonography Gynecology 030219 obstetrics & reproductive medicine Radiological and Ultrasound Technology business.industry Ultrasound Obstetrics and Gynecology General Medicine First trimester Pregnancy Trimester First Reproductive Medicine Cell-free fetal DNA Female business Risk assessment Cell-Free Nucleic Acids |
| Zdroj: | Ultrasound in obstetricsgynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 51(4) |
| ISSN: | 1469-0705 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text